Summary
Elevance Health, Inc. (ELV) has issued a Current Report (8-K) on September 4, 2025, primarily to reaffirm its financial guidance for the full year 2025. The company expects to report diluted earnings per share of approximately $24.10, which includes an estimated $5.90 per diluted share in net unfavorable items. Excluding these specific items, the adjusted earnings per share are projected to be around $30.00, consistent with prior disclosures and not accounting for any additional adjustments beyond those already reported in the second quarter of 2025. Furthermore, Elevance Health is reiterating its guidance for the full year 2025 benefit expense ratio, which is anticipated to be approximately 90.0%. Management attributes these expectations to their current assessment of market conditions, operational performance, the regulatory and policy environment, and refined assumptions regarding cost trends and medical claims payable estimates. Investors are cautioned that actual results may differ materially due to changes in these factors.
Key Highlights
- 1Reaffirmation of 2025 diluted earnings per share guidance at approximately $24.10.
- 2Expectation of approximately $5.90 per diluted share in net unfavorable items for 2025.
- 3Projection of 2025 adjusted shareholders' earnings per diluted share to be approximately $30.00.
- 4Reaffirmation of 2025 benefit expense ratio guidance at approximately 90.0%.
- 5Guidance reflects management's current view of market conditions, operational performance, and regulatory landscape.
- 6No new financial guidance or material updates beyond reaffirmation are provided in this filing.
- 7The company emphasizes that actual results could differ materially from current expectations.